Guozheng Qin

Mr. Guozheng Qin

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2025 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
LXLei Xu
Lei Xu
SCShuai Chen
Shuai Chen
WFWei Fu
Wei Fu
XLXuyao Lin
Xuyao Lin
FZFugang Zhang
Fugang Zhang
BHBin Huang
Bin Huang
As industrial pollution intensifies, global male semen quality has been declining at a rate of 2.64 % per year in the 21st century. Among the various types of infertility, non-obstructive azoospermia (NOA) is the most severe and is closely associated with exposure to environmental toxins. The molecular mechanisms by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a typical persistent organic pollutant, induces NOA have yet to be systematically elucidated. This study employed the single-sample Gene Set Enrichment Analysis (ssGSEA) method to identify key toxicological pathways and constructed a diagnostic model based on 113 machine learning algorithms. By integrating Weighted Gene Co-expression Network Analysis (WGCNA) and single-cell analysis, we identified hub genes associated with the Sertoli Cell-Only Syndrome (SCOS) subtype. Finally, biomolecular modeling was conducted to validate the binding efficacy of the hub genes with TCDD. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis based on the ssGSEA method indicated that TCDD may disrupt spermatogenesis by activating the Tumor Necrosis Factor (TNF) and Mitogen-Activated Protein Kinase (MAPK) signaling pathways while inhibiting the Vascular Endothelial Growth Factor (VEGF) signaling pathway, ultimately leading to NOA. Through the integration of machine learning techniques, 5 hub genes (AUC > 0.7) induced by TCDD and associated with NOA were identified: Androgen receptor (AR), Chromodomain Helicase DNA-Binding Protein 1 (CHD1), Discoidin Domain Receptor Tyrosine Kinase 2 (DDR2), Retinoic Acid Receptor-Related Orphan Receptor Alpha (RORA), and Glutamate Ionotropic Receptor AMPA Type Subunit 1 (GRIA1). WGCNA and single-cell analysis revealed that AR and DDR2 were specifically expressed in the testicular tissues of NOA patients and were closely associated with SCOS (p < 0.05). Immune infiltration analysis suggested that TCDD induces abnormal infiltration of various immune cells, indicating its close relationship with immune inflammatory responses (p < 0.05). Biomolecular modeling further demonstrated a strong binding affinity between AR and TCDD (∆G = -8.3 kcal·mol⁻¹, Etotal = -37.79 kcal·mol⁻¹), highlighting the critical role of AR in TCDD-induced NOA. This study reveals the potential molecular mechanisms by which TCDD induces NOA, providing new targets for the development of diagnostic and therapeutic strategies.

5 March 2021 in Medicine
Verified
Journal Article
Open access
QLQingrui Li
Qingrui Li
CZChao Zhang
Chao Zhang
CLChenxi Li
Chenxi Li
XLXuyao Lin
Xuyao Lin
MWMingkai Wang
Mingkai Wang
GQGuozheng Qin
Guozheng Qin
Background: Sperm DNA fragmentation (SDF) may hinder embryonic development and growth, increasing the risk of spontaneous miscarriage, and is considered an important factor affecting male infertility (MI). Traditional Chinese herbal medicine is considered effective in the treatment of MI due to SDF by nourishing kidney essence or promoting blood circulation for removing blood stasis. The objective of this systematic review protocol is to evaluate the effectiveness and safety of traditional Chinese herbal medicine on the treatment of MI associated with SDF. Methods: We searched the PubMed, Embase, Web of Science, Cochrane Library, CNKI, VIP Chinese Science, Technology Journal Database, and Wanfang Database until the end of 2020 for English and Chinese published literature. Randomized controlled trials (RCTs) to evaluate the effectiveness and safety of traditional Chinese herbal medicine for the treatment of MI associated with SDF will be included. Study selection and data extraction were performed independently by 2 reviewers, and the quality evaluation and risk assessment were assessed by the Cochrane collaboration's tool, and use the RevMan 5.3 software for meta-analysis. Conclusion: This study will evaluate the efficacy and safety of traditional Chinese herbal medicine for the treatment of MI due to SDF, which may provide some help for the clinician's decision. Prospero registration number: CRD42020221053.

10 December 2021 in Medicine
Verified
Journal Article
Open access
CLChenxi Li
Chenxi Li
LXLei Xu
Lei Xu
XLXuyao Lin
Xuyao Lin
QLQingrui Li
Qingrui Li
PYPule Ye
Pule Ye
GQGuozheng Qin
Guozheng Qin
Objective: Chronic prostatitis (CP) is a common disease in the outpatient department of males and urology. Clinical studies have found that acupuncture combined with traditional Chinese medicine (TCM) has achieved good results in treating CP, but its efficacy and safety are not completely clear. This study aimed to investigate the efficacy and safety of acupuncture combined with TCM in the treatment of CP. Methods: Randomized controlled trials of acupuncture combined with TCM in treating CP were screened by searching PubMed, Embase, Cochrane Library, CNKI, etc. The retrieval time was from the database establishment date to March 31, 2021. The Cochrane Collaborative Risk Bias Assessment tool was used to evaluate literature's methodological quality of the literature. The RevMan5.4 software was used for the meta-analysis of outcome indicators. The TSA v0.9 software was used for sequential trial analysis (TSA) of effectiveness. Results: In this study, 19 related randomized controlled trial studies were included, with a total of 1831 cases. The results of the meta-analysis showed that acupuncture combined with TCM could significantly improve the clinical efficacy of CP (OR = 3.76, 95%CI: 2.82 to 5.02, P < .00001), reduce the total score of The National Institutes of Health chronic prostatitis symptom index (MD = −4.00, 95%CI: −4.67 to 3.33, P < .00001), and improve patients’ urination symptoms (MD = −1.10, 95%CI: −1.23 to −0.97, P < .00001), alleviated the pain symptoms of patients (MD = −2.38, 95%CI: −2.41 to −2.35, P < .00001), improved the quality of life of patients (MD = −1.69, 95%CI: −1.97 to −1.41, P < .00001), decreased the scores of TCM symptoms of patients (MD = −2.39, 95%CI: −3.45 to −1.33, P < .00001), and did not increase the adverse reactions of patients (MD = 1.09, 95%CI: 0.57 to 2.06, P = .8). The results of publication bias showed that this study was not affected by publication bias, and the conclusion was reliable. TSA showed that acupuncture combined with TCM was effective in treating CP. Conclusion: Acupuncture combined with TCM is safe and effective for alleviating CP. It can be used as an effective treatment for chronic prostatitis in the clinic. Registration number: DOI 10.17605/OSF.IO/Z8FJM.

12 January 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CLChenxi Li
Chenxi Li
LXLei Xu
Lei Xu
XLXuyao Lin
Xuyao Lin
QLQingrui Li
Qingrui Li
SLShaoming Liu
Shaoming Liu
GQGuozheng Qin
Guozheng Qin
Background. Using network pharmacology and molecular docking, this study aimed to explore the active pharmaceutical ingredients (APIs) and molecular mechanism of Qinshi Simiao San (QSSMS) in the treatment of chronic prostatitis (CP) and verify our findings in the rat model. Methods. The APIs of QSSMS and the common targets of QSSMS and CP were screened from the TCMSP database. The STRING database and Cytoscape software were used to construct the network graph. The enriched GO and KEGG pathways were displayed by David software and R software. Molecular docking was performed to visualize key components and target genes. In addition, the rats model of CP was established to verify the molecular mechanism of QSSMS. Results. Network pharmacology showed that the APIs of QSSMS mainly included quercetin, kaempferol, formononetin, isorhamnetin, and calycosin. QSSMS alleviated CP mainly through the negative regulation of the apoptotic process, oxidation-reduction process, inflammatory response, and immune response. Molecular docking showed that the APIs could bind to the corresponding targets. QSSMS repaired the pathological damage of prostate tissue, upregulated the expression of oxidative stress scavenging enzymes CAT and SOD, and downregulated the peroxidative product MDA, inflammatory factors IL-1β, IL-6, TNF-α, COX-2, PGE2, and NGF, and immune factors IgG and SIgA. Conclusion. The APIs in QSSMS may inhibit inflammation in the rat CP model by regulating immune and oxidative stress.

13 September 2024 in Medicine
Verified
Journal Article
Open access
HLHongying Li
Hongying Li
YYYanfang Mm Yang
Yanfang Mm Yang
MSMenghua Shi
Menghua Shi
LXLei Xu
Lei Xu
HLHongying Li
Hongying Li
GQGuozheng Qin
Guozheng Qin
Background: Traditional Chinese medicine (TCM) posits that chronic prostatitis is associated with the accumulation of damp-heat pathogenic factors in the lower jiao. The Bixie Fenqing decoction (BFD) eliminates damp-heat pathogenic factors in the body, thereby alleviating inflammation and improving symptoms. Methods: Databases such as CNKI, WanFang, VIP, CBM, ClinicalKey, PubMed, Embase, and the Cochrane Library were searched. The search time ranged from the establishment of the database until March 30, 2024. RCTs that used BFD for chronic prostatitis were screened. The methodological quality of the studies was evaluated using the Cochrane Scoring System. Meta-analysis of outcome indicators was performed using RevMan 5.4 software, and Egger analysis of publication bias for the primary outcome indicators was conducted using Stata 16 software. Results: This analysis included 1104 patients. Meta-analysis showed that BFD significantly improved clinical efficacy in patients with chronic prostatitis, with a total effective rate (RR = 1.20, 95% CI: 1.13 to 1.26, P < .00001) and cure rate (RR = 1.52, 95% CI: 1.24 to 1.86, P < .00001). It significantly reduced the NIH-CPSI (National Institutes of Health-Chronic Prostatitis Symptom Index) scores, levels of inflammatory factors, white blood cell counts, and TCM syndrome scores in patients with chronic prostatitis. Specifically, the NIH-CPSI total scores (MD = −4.41, 95% CI: −5.27 to −3.55, P < .00001), NIH-CPSI pain scores (MD = −2.08, 95% CI: −2.93 to −1.23, P < .00001), NIH-CPSI urinary symptom scores (MD = −1.13, 95% CI: −1.69 to −0.57, P < .0001), NIH-CPSI quality of life scores (MD = −1.25, 95% CI: −1.76 to −0.75, P < .00001), levels of inflammatory factors TNF-α (MD = −11.18, 95% CI: −13.84 to −8.53, P <  .00001) and IL-10 (MD = −20.60, 95% CI: −26.82 to −14.37, P < .00001) in prostatic fluid, white blood cell counts in prostatic fluid (MD = −2.91, 95% CI: −5.46 to −0.36, P = .03), and TCM syndrome scores (MD = −7.01, 95% CI: −8.13 to −5.90, P < .00001) were all significantly improved. Conclusion: BFD has a definite effect on the treatment of chronic prostatitis.

11 September 2024 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
LXLei Xu
Lei Xu
MSMenghua Shi
Menghua Shi
GQGuozheng Qin
Guozheng Qin
XLXuyao Lin
Xuyao Lin
BHBin Huang
Bin Huang